arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BIO-RAD LABORATORIES, INC.

BIO
$379.65 ▲ +2.43 (+0.64%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
72 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

BIO-RAD LABORATORIES, INC. shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $10.2B
Dividend Yield
Revenue Growth -0.1%
Op. Margin 11.2%
ROIC 0.6%
FCF / Share $2.49
Trailing P/E 27.3x
Price / Book 1.4x
FCF Yield 0.7%
Debt / Equity 0.17
info Valuation on last close. End-of-day price, Sep 22, 2026.

72-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$651.00M
— -0.1%
Net Income Profit after all expenses
$-527.10M
— 0.0%
Operating Margin Operating profit as % of sales
11.2%
↑ +93.6% 33th
FCF / Share Free cash flow per share
$2.49
↓ -13.9%
Long-Term Debt Long-term obligations
$1.20B
— 0.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
65
Returns
68
Financial Health
65
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 72 quarters